Cargando…
Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer
Lethal prostate cancer (PCa) is characterized by the presence of metastases and development of resistance to therapies. Metastases form in a multi-step process enabled by dynamic cytoskeleton remodeling. An actin cytoskeleton regulating gene, CALD1, encodes a protein caldesmon (CaD). Its isoform, lo...
Autores principales: | Virtanen, Verneri, Paunu, Kreetta, Kukkula, Antti, Niva, Saana, Junila, Ylva, Toriseva, Mervi, Jokilehto, Terhi, Mäkelä, Sari, Huhtaniemi, Riikka, Poutanen, Matti, Paatero, Ilkka, Sundvall, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423232/ https://www.ncbi.nlm.nih.gov/pubmed/37573448 http://dx.doi.org/10.1038/s41389-023-00485-z |
Ejemplares similares
-
PARP Inhibitors in Prostate Cancer–the Preclinical Rationale and Current Clinical Development
por: Virtanen, Verneri, et al.
Publicado: (2019) -
High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice
por: Huhtaniemi, Riikka, et al.
Publicado: (2022) -
Caldesmon: Biochemical and Clinical Implications in Cancer
por: Yao, Yi-Bo, et al.
Publicado: (2021) -
Therapeutic Potential of Targeting the SUMO Pathway in Cancer
por: Kukkula, Antti, et al.
Publicado: (2021) -
Identification by monoclonal antibodies and characterization of human platelet caldesmon
Publicado: (1986)